Clinical study on Bishushi Tablets combined with desloratadine citrate disodium in treatment of allergic rhinitis
Yang-jing CHEN,Hong-hui LI,Rui-min ZHAO,Qian ZHAO
DOI: https://doi.org/10.7501/j.issn.1674-5515.2016.04.028
2016-01-01
Abstract:Objective To explore the clinical efficacy of Bishushi Tablets combined with desloratadine citrate disodium in treatment of allergic rhinitis. Methods Patients (138 cases) with allergic rhinitis in the First Affiliated Hospital of Xi’an Jiaotong University from January 2015 to January 2016 were randomly divided into control and treatment groups, and each group had 69 cases. The patients in the control group were po administered with Desloratadine Citrate Disodium Capsules, 1 grain/time, once daily. The patients in the treatment group were po administered with Bishushi Tablets on the basis of the control group, 5 tablets/time, three times daily. The patients in two groups were treated for 12 d. After treatment, the efficacy was evaluated, and the changes of symptom scores, LTB4, IL-4, IL-10, IL-12, TGF-α, IFN-γ, and IgE in two groups before and after treatment were compared. Results After treatment, the efficacies in the control and treatment groups were 85.51% and 95.65%, respectively, and there were differences between two groups (P < 0.05). After treatment, symptom (including stuffy nose, nasal itching, sneezing, and runny nose) scores, total scores, IL-4, IL-10, TGF-α, LTB4, and IgE in two groups were significantly decreased, IL-12 and IFN-γ were significantly increased, and the difference was statistically significant in the same group (P < 0.05). After treatment, the observational indexes in the treatment group were significantly better than those in the control group, with significant difference between two groups (P < 0.05). Conclusion Bishushi Tablets combined with desloratadine citrate disodium has clinical curative effect in treatment of allergic rhinitis, and can improve the clinical symptoms, also can improve the detection factor levels, which has a certain clinical application value.